BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21(37): 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] [Cited by in CrossRef: 261] [Cited by in F6Publishing: 222] [Article Influence: 43.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun J, Wang F, Ling Z, Yu X, Chen W, Li H, Jin J, Pang M, Zhang H, Yu J, Liu J. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Research 2016;1642:180-8. [DOI: 10.1016/j.brainres.2016.03.042] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
2 Jiang T, Li G, Xu J, Gao S, Chen X. The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit? Front Immunol 2018;9:2047. [PMID: 30319601 DOI: 10.3389/fimmu.2018.02047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
3 Gorlé N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Front Immunol 2020;11:584165. [PMID: 33633723 DOI: 10.3389/fimmu.2020.584165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Franco R, Casanovas B, Camps J, Navarro G, Martínez-Pinilla E. Antixoxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Curr Issues Mol Biol 2021;43:650-64. [PMID: 34287292 DOI: 10.3390/cimb43020047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Panigrahi GP, Rane AR, Vavilala SL, Choudhary S. Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K. The Journal of Biochemistry 2019;166:463-74. [DOI: 10.1093/jb/mvz064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Venkatesan D, Iyer M, Narayanasamy A, Siva K, Vellingiri B. Kynurenine pathway in Parkinson's disease-An update. eNeurologicalSci 2020;21:100270. [PMID: 33134567 DOI: 10.1016/j.ensci.2020.100270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Mirzaei H, Sedighi S, Kouchaki E, Barati E, Dadgostar E, Aschner M, Tamtaji OR. Probiotics and the Treatment of Parkinson's Disease: An Update. Cell Mol Neurobiol 2021. [PMID: 34283340 DOI: 10.1007/s10571-021-01128-w] [Reference Citation Analysis]
8 Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019;328:98-104. [DOI: 10.1016/j.jneuroim.2019.01.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 45.0] [Reference Citation Analysis]
9 Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis 2017;3:3. [PMID: 28649603 DOI: 10.1038/s41531-016-0002-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 188] [Article Influence: 49.8] [Reference Citation Analysis]
10 Principi N, Esposito S. Gut microbiota and central nervous system development. J Infect 2016;73:536-46. [PMID: 27725185 DOI: 10.1016/j.jinf.2016.09.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
11 Chaudhuri KR, Titova N; National Parkinson Foundation Centre of Excellence, King’s College Hospital, Denmark Hill, London, UK, King’s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, London, UK, Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, Moscow, Russian Federation. Societal Burden and Persisting Unmet Needs of Parkinson’s Disease. European Neurological Review 2019;14:28. [DOI: 10.17925/enr.2019.14.1.28] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Stocchi F, Torti M. Constipation in Parkinson's Disease. Int Rev Neurobiol 2017;134:811-26. [PMID: 28805584 DOI: 10.1016/bs.irn.2017.06.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
13 Wang HX, Wang YP. Gut Microbiota-brain Axis. Chin Med J (Engl). 2016;129:2373-2380. [PMID: 27647198 DOI: 10.4103/0366-6999.190667] [Cited by in Crossref: 120] [Cited by in F6Publishing: 87] [Article Influence: 30.0] [Reference Citation Analysis]
14 Molsberry S, Bjornevik K, Hughes KC, Healy B, Schwarzschild M, Ascherio A. Diet pattern and prodromal features of Parkinson disease. Neurology 2020;95:e2095-108. [PMID: 32817391 DOI: 10.1212/WNL.0000000000010523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wallings RL, Herrick MK, Tansey MG. LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's. Front Neurosci 2020;14:443. [PMID: 32508566 DOI: 10.3389/fnins.2020.00443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
16 Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis. Mov Disord Clin Pract 2019;6:639-51. [PMID: 31745471 DOI: 10.1002/mdc3.12840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
17 Lu E, Sarkar S, Raymick J, Paule MG, Gu Q. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Brain Research 2018;1678:432-9. [DOI: 10.1016/j.brainres.2017.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
19 Gao B, Chi L, Tu P, Gao N, Lu K. The Carbamate Aldicarb Altered the Gut Microbiome, Metabolome, and Lipidome of C57BL/6J Mice. Chem Res Toxicol 2019;32:67-79. [PMID: 30406643 DOI: 10.1021/acs.chemrestox.8b00179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
20 Mukherjee A, Biswas A, Das SK. Gut dysfunction in Parkinson's disease. World J Gastroenterol 2016; 22(25): 5742-5752 [PMID: 27433087 DOI: 10.3748/wjg.v22.i25.5742] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 66] [Article Influence: 15.8] [Reference Citation Analysis]
21 Chetty D, Abrahams S, van Coller R, Carr J, Kenyon C, Bardien S. Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment. Eur J Neurosci 2021;54:4695-711. [PMID: 34043864 DOI: 10.1111/ejn.15324] [Reference Citation Analysis]
22 Vaiserman AM, Koliada AK, Marotta F. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Res Rev. 2017;35:36-45. [PMID: 28109835 DOI: 10.1016/j.arr.2017.01.001] [Cited by in Crossref: 166] [Cited by in F6Publishing: 144] [Article Influence: 41.5] [Reference Citation Analysis]
23 Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer's Disease. J Neurogastroenterol Motil 2019;25:48-60. [PMID: 30646475 DOI: 10.5056/jnm18087] [Cited by in Crossref: 212] [Cited by in F6Publishing: 184] [Article Influence: 106.0] [Reference Citation Analysis]
24 Sinha A, Maurice CF. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System. Mediators Inflamm 2019;2019:3730519. [PMID: 31582898 DOI: 10.1155/2019/3730519] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
25 Tan AH, Hor JW, Chong CW, Lim SY. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021;5:414-9. [PMID: 33860090 DOI: 10.1002/jgh3.12450] [Reference Citation Analysis]
26 Vuuren MJV, Nell TA, Carr JA, Kell DB, Pretorius E. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease. Biomolecules 2020;11:E30. [PMID: 33383805 DOI: 10.3390/biom11010030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, Okazaki S, Yamashita S, Miura S, Miki H, Matsuda H, Koike M, Izuhara M, Araki T, Tsuchie K, Azis IA, Arauchi R, Abdullah RA, Oh-nishi A, Horiguchi J. Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clin Neuropharm 2018;41:151-5. [DOI: 10.1097/wnf.0000000000000299] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
28 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 20.0] [Reference Citation Analysis]
29 Brás IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells 2021;10:375. [PMID: 33673034 DOI: 10.3390/cells10020375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Stefano GB, Pilonis N, Ptacek R, Raboch J, Vnukova M, Kream RM. Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. Cell Mol Neurobiol 2018;38:1197-206. [PMID: 29802603 DOI: 10.1007/s10571-018-0589-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
31 Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, Cuzzocrea S, Zappia M, Giordano J, Calabrese EJ, Franceschi C. Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 2018;115:80-91. [PMID: 29080843 DOI: 10.1016/j.freeradbiomed.2017.10.379] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 36.5] [Reference Citation Analysis]
32 Jang JH, Yeom MJ, Ahn S, Oh JY, Ji S, Kim TH, Park HJ. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. Brain Behav Immun 2020;89:641-55. [PMID: 32827699 DOI: 10.1016/j.bbi.2020.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
33 Melis M, Haehner A, Mastinu M, Hummel T, Tomassini Barbarossa I. Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson's Disease. Int J Mol Sci 2021;22:4286. [PMID: 33924222 DOI: 10.3390/ijms22084286] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Cabezudo D, Baekelandt V, Lobbestael E. Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation. Front Neurosci 2020;14:376. [PMID: 32410948 DOI: 10.3389/fnins.2020.00376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
35 Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, Monti D, Capri M, Salvioli S. The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Front Med (Lausanne) 2018;5:61. [PMID: 29662881 DOI: 10.3389/fmed.2018.00061] [Cited by in Crossref: 226] [Cited by in F6Publishing: 206] [Article Influence: 75.3] [Reference Citation Analysis]
36 Ciobanu AM, Ionita I, Buleandra M, David IG, Popa DE, Ciucu AA, Budisteanu M. Current advances in metabolomic studies on non-motor psychiatric manifestations of Parkinson's disease (Review). Exp Ther Med 2021;22:1010. [PMID: 34345292 DOI: 10.3892/etm.2021.10443] [Reference Citation Analysis]
37 Smith LM, Parr-brownlie LC. A neuroscience perspective of the gut theory of Parkinson's disease. Eur J Neurosci 2019;49:817-23. [DOI: 10.1111/ejn.13869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
38 Mawatari S, Sasuga Y, Morisaki T, Okubo M, Emura T, Fujino T. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis. Sci Rep 2020;10:427. [PMID: 31949186 DOI: 10.1038/s41598-019-57309-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Wang X, Wu M. Research progress of gut microbiota and frailty syndrome. Open Med (Wars) 2021;16:1525-36. [PMID: 34712824 DOI: 10.1515/med-2021-0364] [Reference Citation Analysis]
40 Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D. Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope? Clin Interv Aging 2016;11:1601-8. [PMID: 27956826 DOI: 10.2147/CIA.S106284] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
41 Liu B, Sjölander A, Pedersen NL, Ludvigsson JF, Chen H, Fang F, Wirdefeldt K. Irritable bowel syndrome and Parkinson's disease risk: register-based studies. NPJ Parkinsons Dis 2021;7:5. [PMID: 33402695 DOI: 10.1038/s41531-020-00145-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Vuotto C, Battistini L, Caltagirone C, Borsellino G. Gut Microbiota and Disorders of the Central Nervous System. Neuroscientist 2020;26:487-502. [PMID: 32441219 DOI: 10.1177/1073858420918826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
43 Ganci M, Suleyman E, Butt H, Ball M. The role of the brain-gut-microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders. Brain Behav 2019;9:e01408. [PMID: 31568686 DOI: 10.1002/brb3.1408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
44 Kim Y, Lee C, Kim S, Jang J, Lee S, Lee S. Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort. J Neurol 2020;267:513-21. [DOI: 10.1007/s00415-019-09617-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, Yuan Y, Li L. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neurosci Bull 2021. [PMID: 34216356 DOI: 10.1007/s12264-021-00730-8] [Reference Citation Analysis]
46 Zhou JJ, Chun L, Liu JF. A Comprehensive Understanding of Dietary Effects on C. elegans Physiology. Curr Med Sci 2019;39:679-84. [PMID: 31612382 DOI: 10.1007/s11596-019-2091-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Li S, Shao Y, Li K, Huangfu C, Wang W, Liu Z, Cai Z, Zhao B. Vascular Cognitive Impairment and the Gut Microbiota. JAD 2018;63:1209-22. [DOI: 10.3233/jad-171103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
48 Bajracharya R, Youngson NA, Ballard JWO. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease. Int J Mol Sci 2019;20:E1850. [PMID: 30991634 DOI: 10.3390/ijms20081850] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Franco R, Rivas-Santisteban R, Reyes-Resina I, Navarro G, Martínez-Pinilla E. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease. Front Aging Neurosci 2020;12:12. [PMID: 32226375 DOI: 10.3389/fnagi.2020.00012] [Reference Citation Analysis]
50 Kim Y, Clifton P. Curcumin, Cardiometabolic Health and Dementia. Int J Environ Res Public Health 2018;15:E2093. [PMID: 30250013 DOI: 10.3390/ijerph15102093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
51 Smith RP, Easson C, Lyle SM, Kapoor R, Donnelly CP, Davidson EJ, Parikh E, Lopez JV, Tartar JL. Gut microbiome diversity is associated with sleep physiology in humans. PLoS One 2019;14:e0222394. [PMID: 31589627 DOI: 10.1371/journal.pone.0222394] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 22.0] [Reference Citation Analysis]
52 Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 2017;13:457-76. [PMID: 28708131 DOI: 10.1038/nrneurol.2017.96] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 25.8] [Reference Citation Analysis]
53 Gabbianelli R, Damiani E. Epigenetics and neurodegeneration: role of early-life nutrition. The Journal of Nutritional Biochemistry 2018;57:1-13. [DOI: 10.1016/j.jnutbio.2018.01.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
54 Tandon D, Haque MM, R S, Shaikh S, P S, Dubey AK, Mande SS. A snapshot of gut microbiota of an adult urban population from Western region of India. PLoS One 2018;13:e0195643. [PMID: 29624599 DOI: 10.1371/journal.pone.0195643] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
55 Kustrimovic N, Marino F, Cosentino M. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease. Curr Med Chem 2019;26:3719-53. [PMID: 30306855 DOI: 10.2174/0929867325666181009161048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
56 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bumbu AG, Andronie-Cioara FL, Nechifor AC, Gitea D, Bungau AF, Toma MM, Bungau SG. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. Int J Mol Sci 2021;22:6737. [PMID: 34201647 DOI: 10.3390/ijms22136737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Yang Y, Liu S, Wang Y, Wang Z, Ding W, Sun X, He K, Feng Q, Zhang X. Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis. Aging (Albany NY) 2020;12:13090-114. [PMID: 32634783 DOI: 10.18632/aging.103399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson’s Disease and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
59 Choi J, Hur TY, Hong Y. Influence of Altered Gut Microbiota Composition on Aging and Aging-Related Diseases. J Lifestyle Med. 2018;8:1-7. [PMID: 29581954 DOI: 10.15280/jlm.2018.8.1.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
60 Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China. Front Mol Neurosci 2019;12:171. [PMID: 31354427 DOI: 10.3389/fnmol.2019.00171] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
61 Guo Y, Wang B, Wang T, Gao L, Yang ZJ, Wang FF, Shang HW, Hua R, Xu JD. Biological characteristics of IL-6 and related intestinal diseases. Int J Biol Sci 2021;17:204-19. [PMID: 33390844 DOI: 10.7150/ijbs.51362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metab Brain Dis 2021. [PMID: 34370175 DOI: 10.1007/s11011-021-00808-2] [Reference Citation Analysis]
63 Xie X, Luo X, Xie M. Association between Parkinson's disease and risk of colorectal cancer. Parkinsonism Relat Disord 2017;35:42-7. [PMID: 27913126 DOI: 10.1016/j.parkreldis.2016.11.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
64 Cosma-Grigorov A, Meixner H, Mrochen A, Wirtz S, Winkler J, Marxreiter F. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates. Front Neurol 2020;11:1041. [PMID: 33071933 DOI: 10.3389/fneur.2020.01041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
65 Arneth BM. Gut–brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. Postgrad Med J 2018;94:446-52. [DOI: 10.1136/postgradmedj-2017-135424] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
66 Gadecka A, Bielak-Zmijewska A. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients 2019;11:E1251. [PMID: 31159371 DOI: 10.3390/nu11061251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
67 Del Chierico F, Grassini P, Quagliariello A, Torti M, Russo A, Reddel S, Stocchi F. The impact of intestinal microbiota on weight loss in Parkinson's disease patients: a pilot study. Future Microbiol 2020;15:1393-404. [PMID: 33085540 DOI: 10.2217/fmb-2019-0336] [Reference Citation Analysis]
68 Gómez-Gómez ME, Zapico SC. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions. Int J Mol Sci 2019;20:E2842. [PMID: 31212645 DOI: 10.3390/ijms20112842] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
69 Franco R, Reyes-Resina I, Navarro G. Dopamine in Health and Disease: Much More Than a Neurotransmitter. Biomedicines 2021;9:109. [PMID: 33499192 DOI: 10.3390/biomedicines9020109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
70 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Bhattarai Y, Kashyap PC. Parkinson's disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol 2020;319:G529-40. [PMID: 32877215 DOI: 10.1152/ajpgi.00058.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Yang G, Jiang Y, Yang W, Du F, Yao Y, Shi C, Wang C. Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide. Microb Cell Fact 2015;14:202. [PMID: 26691527 DOI: 10.1186/s12934-015-0394-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
73 Mulak A, Koszewicz M, Panek-Jeziorna M, Koziorowska-Gawron E, Budrewicz S. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease. Front Neurosci 2019;13:992. [PMID: 31611762 DOI: 10.3389/fnins.2019.00992] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
74 Shannon K, Vanden Berghe P. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell Tissue Res 2018;373:313-26. [PMID: 29936550 DOI: 10.1007/s00441-018-2856-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
75 Khan F, Oloketuyi SF. A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota. J Appl Microbiol 2017;122:306-20. [PMID: 27740729 DOI: 10.1111/jam.13327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
76 Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
77 Ekmark-Lewén S, Lindström V, Gumucio A, Ihse E, Behere A, Kahle PJ, Nordström E, Eriksson M, Erlandsson A, Bergström J, Ingelsson M. Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice. Brain Behav 2018;8:e00915. [PMID: 29541535 DOI: 10.1002/brb3.915] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
78 Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW, O'Mahony SM. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 2016;27:1-8. [PMID: 27013171 DOI: 10.1016/j.parkreldis.2016.03.012] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 20.4] [Reference Citation Analysis]
79 Sun Q, Cheng L, Zeng X, Zhang X, Wu Z, Weng P. The modulatory effect of plant polysaccharides on gut flora and the implication for neurodegenerative diseases from the perspective of the microbiota-gut-brain axis. International Journal of Biological Macromolecules 2020;164:1484-92. [DOI: 10.1016/j.ijbiomac.2020.07.208] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
80 Sfera A, Bullock K, Price A, Inderias L, Osorio C. Ferrosenescence: The iron age of neurodegeneration? Mech Ageing Dev 2018;174:63-75. [PMID: 29180225 DOI: 10.1016/j.mad.2017.11.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
81 Konjevod M, Nikolac Perkovic M, Sáiz J, Svob Strac D, Barbas C, Rojo D. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. J Pharm Biomed Anal 2021;194:113681. [PMID: 33279302 DOI: 10.1016/j.jpba.2020.113681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
82 Mathis SP, Bodduluri SR, Haribabu B. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158982. [PMID: 34062254 DOI: 10.1016/j.bbalip.2021.158982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci 2017;60:1223-33. [DOI: 10.1007/s11427-016-9001-4] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 31.5] [Reference Citation Analysis]
84 Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2019;25:363-76. [PMID: 31327219 DOI: 10.5056/jnm19044] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 24.5] [Reference Citation Analysis]
85 Qian Y, Yang X, Xu S, Wu C, Qin N, Chen SD, Xiao Q. Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson's Disease. Front Aging Neurosci 2018;10:156. [PMID: 29881345 DOI: 10.3389/fnagi.2018.00156] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
86 Caputi V, Giron MC. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Int J Mol Sci. 2018;19. [PMID: 29882798 DOI: 10.3390/ijms19061689] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 35.7] [Reference Citation Analysis]
87 Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease. Curr Behav Neurosci Rep 2017;4:361-8. [PMID: 29201595 DOI: 10.1007/s40473-017-0129-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
88 Berstad K, Berstad JER. Parkinson's disease; the hibernating spore hypothesis. Med Hypotheses 2017;104:48-53. [PMID: 28673590 DOI: 10.1016/j.mehy.2017.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
89 Diwakarla S, McQuade RM, Constable R, Artaiz O, Lei E, Barnham KJ, Adlard PA, Cherny RA, Di Natale MR, Wu H, Chai XY, Lawson VA, Finkelstein DI, Furness JB. ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease. J Parkinsons Dis 2021. [PMID: 34366375 DOI: 10.3233/JPD-212731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Uyar GÖ, Yildiran H. A nutritional approach to microbiota in Parkinson's disease. Biosci Microbiota Food Health 2019;38:115-27. [PMID: 31763115 DOI: 10.12938/bmfh.19-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
91 Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol 2020;115:165-78. [PMID: 32023228 DOI: 10.14309/ajg.0000000000000501] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 60.0] [Reference Citation Analysis]
92 Singh Y, El-Hadidi M, Admard J, Wassouf Z, Schulze-Hentrich JM, Kohlhofer U, Quintanilla-Martinez L, Huson D, Riess O, Casadei N. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease. Front Neurosci 2019;13:1032. [PMID: 31749671 DOI: 10.3389/fnins.2019.01032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Shen L. Gut, oral and nasal microbiota and Parkinson's disease. Microb Cell Fact 2020;19:50. [PMID: 32103766 DOI: 10.1186/s12934-020-01313-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
95 Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res 2020;252:357-450. [PMID: 32247371 DOI: 10.1016/bs.pbr.2020.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
96 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci 2021;15:691136. [PMID: 34305533 DOI: 10.3389/fncel.2021.691136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Liu X, Liu S, Tang Y, Pu Z, Xiao H, Gao J, Yin Q, Jia Y, Bai Q. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease. Neurochem Res 2021;46:1514-39. [PMID: 33719004 DOI: 10.1007/s11064-021-03293-2] [Reference Citation Analysis]
98 Dong XL, Wang X, Liu F, Liu X, Du ZR, Li RW, Xue CH, Wong KH, Wong WT, Zhao Q, Tang QJ. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. Int J Biol Macromol 2020;164:994-1005. [PMID: 32710966 DOI: 10.1016/j.ijbiomac.2020.07.180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
99 Luna-Herrera C, Martínez-Dávila IA, Soto-Rojas LO, Flores-Martinez YM, Fernandez-Parrilla MA, Ayala-Davila J, León-Chavez BA, Soto-Rodriguez G, Blanco-Alvarez VM, Lopez-Salas FE, Gutierrez-Castillo ME, Gatica-Garcia B, Padilla-Viveros A, Bañuelos C, Reyes-Corona D, Espadas-Alvarez AJ, Garcés-Ramírez L, Hidalgo-Alegria O, De La Cruz-López F, Martinez-Fong D. Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra. J Immunol Res 2020;2020:5907591. [PMID: 33282962 DOI: 10.1155/2020/5907591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Priyadarsini S, Sahoo M, Sahu S, Jayabalan R, Mishra M. An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster. Invert Neurosci 2019;19:13. [PMID: 31641932 DOI: 10.1007/s10158-019-0233-y] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
101 Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease. Brain Sci 2020;10:E206. [PMID: 32244769 DOI: 10.3390/brainsci10040206] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 24.0] [Reference Citation Analysis]
102 Lopresti AL. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Adv Nutr 2018;9:41-50. [PMID: 29438458 DOI: 10.1093/advances/nmx011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 38.0] [Reference Citation Analysis]
103 De Miranda BR, Greenamyre JT. Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease. Environ Sci Process Impacts 2020;22:543-54. [PMID: 31996877 DOI: 10.1039/c9em00578a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Sharma S, Awasthi A, Singh S. Altered gut microbiota and intestinal permeability in Parkinson’s disease: Pathological highlight to management. Neuroscience Letters 2019;712:134516. [DOI: 10.1016/j.neulet.2019.134516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
105 Nan H, Natori T, Ichinose Y, Koh K, Takiyama Y. Conjugal multiple system atrophy: Computing chance or investigating real patients? Parkinsonism Relat Disord 2020;75:122-3. [PMID: 32199744 DOI: 10.1016/j.parkreldis.2020.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Vidal-Martinez G, Chin B, Camarillo C, Herrera GV, Yang B, Sarosiek I, Perez RG. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. J Parkinsons Dis 2020;10:185-92. [PMID: 31561385 DOI: 10.3233/JPD-191693] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
107 Shang Q, Wang Y, Pan L, Niu Q, Li C, Jiang H, Cai C, Hao J, Li G, Yu G. Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp. Mar Drugs 2018;16:E167. [PMID: 29772753 DOI: 10.3390/md16050167] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
108 Sudheer S, Gangwar P, Usmani Z, Sharma M, Sharma VK, Sana SS, Almeida F, Dubey NK, Singh DP, Dilbaghi N, Khayat Kashani HR, Gupta VK, Singh BN, Khayatkashani M, Nabavi SM. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases. Biochimie 2021:S0300-9084(21)00247-9. [PMID: 34688789 DOI: 10.1016/j.biochi.2021.10.010] [Reference Citation Analysis]
109 Roy M, Péré M, Damier P, Bruley des Varannes S, Derkinderen P, Rouaud T. STW5 (Iberogast®) for constipation in Parkinson's disease. Rev Neurol (Paris) 2021;177:296-301. [PMID: 32829914 DOI: 10.1016/j.neurol.2020.06.005] [Reference Citation Analysis]
110 Valderhaug VD, Heiney K, Ramstad OH, Bråthen G, Kuan WL, Nichele S, Sandvig A, Sandvig I. Early functional changes associated with alpha-synuclein proteinopathy in engineered human neural networks. Am J Physiol Cell Physiol 2021;320:C1141-52. [PMID: 33950697 DOI: 10.1152/ajpcell.00413.2020] [Reference Citation Analysis]
111 Witt ST, Bednarska O, Keita ÅV, Icenhour A, Jones MP, Elsenbruch S, Söderholm JD, Engström M, Mayer EA, Walter S. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome. Neuroimage Clin 2019;21:101602. [PMID: 30472166 DOI: 10.1016/j.nicl.2018.11.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
112 Baumuratov AS, Antony PM, Ostaszewski M, He F, Salamanca L, Antunes L, Weber J, Longhino L, Derkinderen P, Koopman WJ, Diederich NJ. Enteric neurons from Parkinson's disease patients display ex vivo aberrations in mitochondrial structure. Sci Rep 2016;6:33117. [PMID: 27624977 DOI: 10.1038/srep33117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
113 Alipour Nosrani E, Tamtaji OR, Alibolandi Z, Sarkar P, Ghazanfari M, Azami Tameh A, Taghizadeh M, Banikazemi Z, Hadavi R, Naderi Taheri M. Neuroprotective effects of probiotics bacteria on animal model of Parkinson's disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. J Immunoassay Immunochem 2021;42:106-20. [PMID: 33078659 DOI: 10.1080/15321819.2020.1833917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
114 Meštrović T, Matijašić M, Perić M, Čipčić Paljetak H, Barešić A, Verbanac D. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics (Basel) 2020;11:E7. [PMID: 33375202 DOI: 10.3390/diagnostics11010007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
115 Blivet G, Meunier J, Roman FJ, Touchon J. Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested. Alzheimers Dement (N Y) 2018;4:54-63. [PMID: 29955652 DOI: 10.1016/j.trci.2017.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
116 Lerner A, Neidhöfer S, Matthias T. The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists. Microorganisms 2017;5:E66. [PMID: 29023380 DOI: 10.3390/microorganisms5040066] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
117 Stefano GB, Kream RM. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders. Cell Mol Neurobiol 2021. [PMID: 34117968 DOI: 10.1007/s10571-021-01117-z] [Reference Citation Analysis]
118 Abo El Gheit RE, Atef MM, El Deeb OS, Badawi GA, Alshenawy HA, Elwan WM, Arakeep HM, Emam MN. Unique Novel Role of Adropin in a Gastric Ulcer in a Rotenone-Induced Rat Model of Parkinson's Disease. ACS Chem Neurosci 2020;11:3077-88. [PMID: 32833426 DOI: 10.1021/acschemneuro.0c00424] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Natale G, Ryskalin L, Morucci G, Lazzeri G, Frati A, Fornai F. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson's Disease. Life (Basel) 2021;11:732. [PMID: 34440476 DOI: 10.3390/life11080732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 James DM, Davidson EA, Yanes J, Moshiree B, Dallman JE. The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Front Cell Dev Biol 2021;9:662916. [PMID: 33937265 DOI: 10.3389/fcell.2021.662916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep 2017;17:94. [PMID: 29039142 DOI: 10.1007/s11910-017-0802-6] [Cited by in Crossref: 205] [Cited by in F6Publishing: 185] [Article Influence: 51.3] [Reference Citation Analysis]
122 Klatt S, Doecke JD, Roberts A, Boughton BA, Masters CL, Horne M, Roberts BR. A six-metabolite panel as potential blood-based biomarkers for Parkinson's disease. NPJ Parkinsons Dis 2021;7:94. [PMID: 34650080 DOI: 10.1038/s41531-021-00239-x] [Reference Citation Analysis]
123 González S, Salazar N, Ruiz-Saavedra S, Gómez-Martín M, de Los Reyes-Gavilán CG, Gueimonde M. Long-Term Coffee Consumption is Associated with Fecal Microbial Composition in Humans. Nutrients 2020;12:E1287. [PMID: 32369976 DOI: 10.3390/nu12051287] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
124 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 21.5] [Reference Citation Analysis]
125 A. Flameling I, T. Rijkers G. Fecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease. In: Evrensel A, Önen Ünsalver B, editors. Gut Microbiota - Brain Axis. IntechOpen; 2018. [DOI: 10.5772/intechopen.78666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann Neurol 2021;89:546-59. [PMID: 33274480 DOI: 10.1002/ana.25982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
127 Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacol Ther 2021;:107988. [PMID: 34536490 DOI: 10.1016/j.pharmthera.2021.107988] [Reference Citation Analysis]
128 Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Digestive and Liver Disease 2018;50:421-8. [DOI: 10.1016/j.dld.2018.02.012] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 30.7] [Reference Citation Analysis]
129 Haikal C, Chen QQ, Li JY. Microbiome changes: an indicator of Parkinson's disease? Transl Neurodegener 2019;8:38. [PMID: 31890161 DOI: 10.1186/s40035-019-0175-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
130 Perez-pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. European Journal of Pharmacology 2017;817:86-95. [DOI: 10.1016/j.ejphar.2017.05.042] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 22.3] [Reference Citation Analysis]
131 Georgopoulos P, Mytilekas K, Apostolidis A. Degenerative Diseases (Multiple Sclerosis, Parkinson’s Disease). In: Dmochowski R, Heesakkers J, editors. Neuro-Urology. Cham: Springer International Publishing; 2018. pp. 55-79. [DOI: 10.1007/978-3-319-90997-4_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Yue Q, Cai M, Xiao B, Zhan Q, Zeng C. The Microbiota-Gut-Brain Axis and Epilepsy. Cell Mol Neurobiol 2021. [PMID: 34279746 DOI: 10.1007/s10571-021-01130-2] [Reference Citation Analysis]
133 Kamimura I, Kaneko R, Morita H, Mogi K, Kikusui T. Microbial colonization history modulates anxiety-like and complex social behavior in mice. Neurosci Res. 2020;. [PMID: 32017965 DOI: 10.1016/j.neures.2020.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Richards AL, Burns MB, Alazizi A, Barreiro LB, Pique-Regi R, Blekhman R, Luca F. Genetic and transcriptional analysis of human host response to healthy gut microbiota. mSystems 2016;1:e00067-16. [PMID: 27709125 DOI: 10.1128/mSystems.00067-16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
135 Gorlé N, Blaecher C, Bauwens E, Vandendriessche C, Balusu S, Vandewalle J, Van Cauwenberghe C, Van Wonterghem E, Van Imschoot G, Liu C, Ducatelle R, Libert C, Haesebrouck F, Smet A, Vandenbroucke RE. The choroid plexus epithelium as a novel player in the stomach-brain axis during Helicobacter infection. Brain Behav Immun 2018;69:35-47. [PMID: 29258921 DOI: 10.1016/j.bbi.2017.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
136 Riccio P, Rossano R. Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity. Nutrients 2019;11:E2714. [PMID: 31717475 DOI: 10.3390/nu11112714] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
137 Pu Y, Chang L, Qu Y, Wang S, Zhang K, Hashimoto K. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain. Aging (Albany NY) 2019;11:6915-29. [PMID: 31479418 DOI: 10.18632/aging.102221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
138 Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R, Uva P, Perra D, Madau V, Sarchioto M, Oppo V, Simola N, Morelli M, Santoru ML, Atzori L, Melis M, Cossu G, Manzin A. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. mSystems 2020;5:e00561-20. [PMID: 32934117 DOI: 10.1128/mSystems.00561-20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
139 Troisi J, Landolfi A, Cavallo P, Marciano F, Barone P, Amboni M. Metabolomics in Parkinson's disease. Adv Clin Chem 2021;104:107-49. [PMID: 34462054 DOI: 10.1016/bs.acc.2020.09.003] [Reference Citation Analysis]
140 El-Hakim Y, Mani KK, Eldouh A, Pandey S, Grimaldo MT, Dabney A, Pilla R, Sohrabji F. Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats. Biol Sex Differ 2021;12:14. [PMID: 33451354 DOI: 10.1186/s13293-020-00352-1] [Reference Citation Analysis]
141 Sato M, Arakaki R, Tawara H, Tsunematsu T, Ishimaru N. Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice. Int J Mol Sci 2021;22:3239. [PMID: 33810172 DOI: 10.3390/ijms22063239] [Reference Citation Analysis]
142 Ma X, Wang Q, Yuan W, Wang Y, Zhou F, Kang K, Tong X, Liu Z. Electroacupuncture Alleviates Neuroinflammation and Motor Dysfunction by Regulating Intestinal Barrier Function in a Mouse Model of Parkinson Disease. J Neuropathol Exp Neurol 2021:nlab046. [PMID: 34343334 DOI: 10.1093/jnen/nlab046] [Reference Citation Analysis]
143 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
144 Adams B, Nunes JM, Page MJ, Roberts T, Carr J, Nell TA, Kell DB, Pretorius E. Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Front Aging Neurosci 2019;11:210. [PMID: 31507404 DOI: 10.3389/fnagi.2019.00210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
145 Rezaie A, Pimentel M, Rao SS. How to Test and Treat Small Intestinal Bacterial Overgrowth: An Evidence-Based Approach. Curr Gastroenterol Rep. 2016;18:8. [PMID: 26780631 DOI: 10.1007/s11894-015-0482-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 13.6] [Reference Citation Analysis]
146 de la Fuente-Nunez C, Meneguetti BT, Franco OL, Lu TK. Neuromicrobiology: How Microbes Influence the Brain. ACS Chem Neurosci 2018;9:141-50. [PMID: 29220570 DOI: 10.1021/acschemneuro.7b00373] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
147 Ward RJ, Dexter DT, Martin-Bastida A, Crichton RR. Is Chelation Therapy a Potential Treatment for Parkinson's Disease? Int J Mol Sci 2021;22:3338. [PMID: 33805195 DOI: 10.3390/ijms22073338] [Reference Citation Analysis]
148 Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson's Disease Mice Model. Front Aging Neurosci 2021;13:649627. [PMID: 33912026 DOI: 10.3389/fnagi.2021.649627] [Reference Citation Analysis]
149 Li X, Feng X, Jiang Z, Jiang Z. Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis. Gut Pathog 2021;13:25. [PMID: 33863370 DOI: 10.1186/s13099-021-00420-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Szablewski L. Human Gut Microbiota in Health and Alzheimer’s Disease. JAD 2018;62:549-60. [DOI: 10.3233/jad-170908] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 10.7] [Reference Citation Analysis]
151 Cova I, Priori A. Diagnostic biomarkers for Parkinson's disease at a glance: where are we? J Neural Transm (Vienna) 2018;125:1417-32. [PMID: 30145631 DOI: 10.1007/s00702-018-1910-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
152 Mehrabadi S, Sadr SS. Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats. Iran Biomed J 2020;24:220-8. [PMID: 32306720 DOI: 10.29252/ibj.24.4.220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
153 McGee DJ, Lu XH, Disbrow EA. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease. J Parkinsons Dis 2018;8:367-74. [PMID: 29966206 DOI: 10.3233/JPD-181327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 14.5] [Reference Citation Analysis]
154 Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017;183:213-24. [PMID: 28286112 DOI: 10.1016/j.clim.2017.03.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
155 Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease. Curr Neuropharmacol 2021;19:233-47. [PMID: 32504503 DOI: 10.2174/1570159X18666200606233050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
156 Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2021;69:101347. [PMID: 33905953 DOI: 10.1016/j.arr.2021.101347] [Reference Citation Analysis]
157 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Reference Citation Analysis]
159 Chatterjee K, Banerjee S. Microbiome and motor neuron diseases. Prog Mol Biol Transl Sci 2020;176:111-22. [PMID: 33814112 DOI: 10.1016/bs.pmbts.2020.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Chandra S, Alam MT, Dey J, Sasidharan BCP, Ray U, Srivastava AK, Gandhi S, Tripathi PP. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Curr Top Med Chem 2020;20:1142-53. [PMID: 32282304 DOI: 10.2174/1568026620666200413091101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
161 Kumpitsch C, Koskinen K, Schöpf V, Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol 2019;17:87. [PMID: 31699101 DOI: 10.1186/s12915-019-0703-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 33.5] [Reference Citation Analysis]
162 Ren W, Wu J, Li L, Lu Y, Shao Y, Qi Y, Xu B, He Y, Hu Y. Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats. J Nutr Health Aging 2018;22:731-8. [DOI: 10.1007/s12603-018-1022-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
163 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
164 Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neuroscience Letters 2019;707:134297. [DOI: 10.1016/j.neulet.2019.134297] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
165 Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. J Neurogastroenterol Motil 2018;24:30-42. [PMID: 29291606 DOI: 10.5056/jnm17105] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 19.7] [Reference Citation Analysis]
166 Bjørklund G, Pivina L, Dadar M, Meguid NA, Semenova Y, Anwar M, Chirumbolo S. Gastrointestinal alterations in autism spectrum disorder: What do we know? Neuroscience & Biobehavioral Reviews 2020;118:111-20. [DOI: 10.1016/j.neubiorev.2020.06.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
167 Lin X, Chen Y, Zhang P, Chen G, Zhou Y, Yu X. The potential mechanism of postoperative cognitive dysfunction in older people. Exp Gerontol 2020;130:110791. [PMID: 31765741 DOI: 10.1016/j.exger.2019.110791] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
168 Wasim S, Kukkar V, Awad VM, Sakhamuru S, Malik BH. Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature. Cureus 2020;12:e9578. [PMID: 32923185 DOI: 10.7759/cureus.9578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
169 Yang X, Qian Y, Xu S, Song Y, Xiao Q. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Front Aging Neurosci 2017;9:441. [PMID: 29358918 DOI: 10.3389/fnagi.2017.00441] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
170 Ilie OD, Ciobica A, McKenna J, Doroftei B, Mavroudis I. Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxid Med Cell Longev 2020;2020:4518023. [PMID: 32089768 DOI: 10.1155/2020/4518023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
171 Quigley EMM. What can we learn from other clinical settings on the influence of the gut microbiome on the brain? Clin Liver Dis (Hoboken) 2017;9:52-4. [PMID: 30992957 DOI: 10.1002/cld.614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
172 van Erp S, Ercan E, Breedveld P, Brakenhoff L, Ghariq E, Schmid S, Osch MV, van Buchem M, Emmer B, van der Grond J, Wolterbeek R, Hommes D, Fidder H, van der Wee N, Huizinga T, van der Heijde D, Middelkoop H, Ronen I, van der Meulen-de Jong A. Cerebral magnetic resonance imaging in quiescent Crohn’s disease patients with fatigue. World J Gastroenterol 2017; 23(6): 1018-1029 [PMID: 28246475 DOI: 10.3748/wjg.v23.i6.1018] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
173 Vargas JY, Grudina C, Zurzolo C. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease. Ageing Res Rev 2019;50:89-101. [PMID: 30690184 DOI: 10.1016/j.arr.2019.01.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
174 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Fessler J, Matson V, Gajewski TF. Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer 2019;7:108. [PMID: 30995949 DOI: 10.1186/s40425-019-0574-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 42.0] [Reference Citation Analysis]
176 Lin X, Liu Y, Ma L, Ma X, Shen L, Ma X, Chen Z, Chen H, Li D, Su Z, Chen X. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice. J Transl Med 2021;19:317. [PMID: 34301274 DOI: 10.1186/s12967-021-02995-z] [Reference Citation Analysis]
177 Quigley EM. Basic Definitions and Concepts: Organization of the Gut Microbiome. Gastroenterol Clin North Am 2017;46:1-8. [PMID: 28164844 DOI: 10.1016/j.gtc.2016.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
178 Yang C, Gao J, Du J, Yang X, Jiang J. Altered Neuroendocrine Immune Responses, a Two-Sword Weapon against Traumatic Inflammation. Int J Biol Sci 2017;13:1409-19. [PMID: 29209145 DOI: 10.7150/ijbs.21916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
179 Jellinger KA. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders. J Neural Transm (Vienna) 2019;126:933-95. [PMID: 31214855 DOI: 10.1007/s00702-019-02028-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
180 Giuffrè M, Moretti R, Campisciano G, da Silveira ABM, Monda VM, Comar M, Di Bella S, Antonello RM, Luzzati R, Crocè LS. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. J Clin Med 2020;9:E3705. [PMID: 33218203 DOI: 10.3390/jcm9113705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
181 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain Behav Immun 2020;90:26-46. [PMID: 32739365 DOI: 10.1016/j.bbi.2020.07.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
182 Jiang C, Li G, Huang P, Liu Z, Zhao B. The Gut Microbiota and Alzheimer's Disease. J Alzheimers Dis. 2017;58:1-15. [PMID: 28372330 DOI: 10.3233/jad-161141] [Cited by in Crossref: 279] [Cited by in F6Publishing: 156] [Article Influence: 93.0] [Reference Citation Analysis]
183 Raval U, Harary JM, Zeng E, Pasinetti GM. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders. Expert Rev Neurother 2020;20:673-86. [PMID: 32459513 DOI: 10.1080/14737175.2020.1775585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
184 Ogden HB, Fallowfield JL, Child RB, Davison G, Fleming SC, Edinburgh RM, Delves SK, Millyard A, Westwood CS, Layden JD. Reliability of gastrointestinal barrier integrity and microbial translocation biomarkers at rest and following exertional heat stress. Physiol Rep 2020;8:e14374. [PMID: 32170836 DOI: 10.14814/phy2.14374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
185 Erturk-Hasdemir D, Kasper DL. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor. Ann N Y Acad Sci 2018;1417:116-29. [PMID: 29528123 DOI: 10.1111/nyas.13660] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
186 Di Sabatino A, Lenti MV, Cammalleri L, Corazza GR, Pilotto A. Frailty and the gut. Dig Liver Dis 2018;50:533-41. [PMID: 29628357 DOI: 10.1016/j.dld.2018.03.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
187 Nunes JM, Fillis T, Page MJ, Venter C, Lancry O, Kell DB, Windberger U, Pretorius E. Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics. Front Immunol 2020;11:1551. [PMID: 32793214 DOI: 10.3389/fimmu.2020.01551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
188 Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, Cho S, Zaidi H, Casey ME, Wahl RL. Dynamic whole-body PET imaging: principles, potentials and applications. Eur J Nucl Med Mol Imaging 2019;46:501-18. [PMID: 30269154 DOI: 10.1007/s00259-018-4153-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
189 Iriondo-DeHond A, Uranga JA, Del Castillo MD, Abalo R. Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain-Gut Axis. Nutrients 2020;13:E88. [PMID: 33383958 DOI: 10.3390/nu13010088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
190 Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A. Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women. Mov Disord 2018;33:1492-6. [PMID: 30218460 DOI: 10.1002/mds.109] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
191 Zhao X, Ai J, Mao H, Gao X. Effects of Eclipta prostrata on gut microbiota of SAMP6 mice with osteoporosis. Journal of Medical Microbiology 2019;68:402-16. [DOI: 10.1099/jmm.0.000936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
192 Shi Y, Qiao CM, Zhou Y, Wu J, Cui C, Hong H, Jia XB, Huang SB, Yao L, Zhao WJ, Shen YQ. Protective effects of prucalopride in MPTP-induced Parkinson's disease mice: Neurochemistry, motor function and gut barrier. Biochem Biophys Res Commun 2021;556:16-22. [PMID: 33836343 DOI: 10.1016/j.bbrc.2021.03.109] [Reference Citation Analysis]
193 Olsen I, Kell DB, Pretorius E. Is Porphyromonas gingivalis involved in Parkinson's disease? Eur J Clin Microbiol Infect Dis 2020;39:2013-8. [PMID: 32564247 DOI: 10.1007/s10096-020-03944-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
194 Minalyan A, Gabrielyan L, Pietra C, Taché Y, Wang L. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats. Front Integr Neurosci 2019;13:13. [PMID: 31031602 DOI: 10.3389/fnint.2019.00013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
195 Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017;74:3769-87. [PMID: 28643167 DOI: 10.1007/s00018-017-2550-9] [Cited by in Crossref: 170] [Cited by in F6Publishing: 153] [Article Influence: 42.5] [Reference Citation Analysis]
196 Wang H, Yang F, Xin R, Cui D, He J, Zhang S, Sun Y. The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome. Biomed Pharmacother 2020;129:110449. [PMID: 32768944 DOI: 10.1016/j.biopha.2020.110449] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
197 Liu L, Liu X. Contributions of Drug Transporters to Blood-Brain Barriers. Adv Exp Med Biol 2019;1141:407-66. [PMID: 31571171 DOI: 10.1007/978-981-13-7647-4_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
198 Lerner A, Matthias T; 1 B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. . AIMS Biophysics 2016;3:546-52. [DOI: 10.3934/biophy.2016.4.546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
199 He J, Zhu G, Wang G, Zhang F. Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration. Oxid Med Cell Longev 2020;2020:6137521. [PMID: 32714488 DOI: 10.1155/2020/6137521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
200 Singh Y, Trautwein C, Dhariwal A, Salker MS, Alauddin M, Zizmare L, Pelzl L, Feger M, Admard J, Casadei N, Föller M, Pachauri V, Park DS, Mak TW, Frick JS, Wallwiener D, Brucker SY, Lang F, Riess O. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Sci Rep 2020;10:16131. [PMID: 32999308 DOI: 10.1038/s41598-020-72903-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Peterson CT. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. J Evid Based Integr Med 2020;25:2515690X20957225. [PMID: 33092396 DOI: 10.1177/2515690X20957225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
202 Mulak A. An overview of the neuroendocrine system in Parkinson's disease: what is the impact on diagnosis and treatment? Expert Rev Neurother 2020;20:127-35. [PMID: 31829756 DOI: 10.1080/14737175.2020.1701437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
203 Tetz G, Brown SM, Hao Y, Tetz V. Parkinson's disease and bacteriophages as its overlooked contributors. Sci Rep 2018;8:10812. [PMID: 30018338 DOI: 10.1038/s41598-018-29173-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
204 Sun BH, Wang T, Li NY, Wu Q, Qiao J. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World J Gastrointest Pharmacol Ther 2021;12:21-31. [PMID: 33564494 DOI: 10.4292/wjgpt.v12.i1.21] [Reference Citation Analysis]
205 Caruso V, Song X, Asquith M, Karstens L. Performance of Microbiome Sequence Inference Methods in Environments with Varying Biomass. mSystems 2019;4:e00163-18. [PMID: 30801029 DOI: 10.1128/mSystems.00163-18] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 25.5] [Reference Citation Analysis]
206 Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Mov Disord 2018;33:1306-14. [PMID: 30098269 DOI: 10.1002/mds.27390] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 18.3] [Reference Citation Analysis]
207 Shao Y, Le W. Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease. Mol Neurodegener 2019;14:3. [PMID: 30634989 DOI: 10.1186/s13024-018-0304-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 29.0] [Reference Citation Analysis]
208 Li L, Lu J, Sun Y, Jin X. Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1. Saudi J Biol Sci 2019;26:1948-55. [PMID: 31889778 DOI: 10.1016/j.sjbs.2019.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
209 Beck BR, Park GS, Jeong DY, Lee YH, Im S, Song WH, Kang J. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of Lactobacillus Strains Isolated From Newborns and Their Impact on Gut Microbiota and Ileal Transcriptome in a Healthy Murine Model. Front Cell Infect Microbiol 2019;9:269. [PMID: 31404163 DOI: 10.3389/fcimb.2019.00269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
210 Gerhardt S, Mohajeri MH. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. Nutrients 2018;10:E708. [PMID: 29857583 DOI: 10.3390/nu10060708] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 33.3] [Reference Citation Analysis]
211 Myers SA, Gobejishvili L, Saraswat Ohri S, Garrett Wilson C, Andres KR, Riegler AS, Donde H, Joshi-Barve S, Barve S, Whittemore SR. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiol Dis 2019;124:353-63. [PMID: 30557659 DOI: 10.1016/j.nbd.2018.12.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
212 Ismail T, Donati-Zeppa S, Akhtar S, Turrini E, Layla A, Sestili P, Fimognari C. Coffee in cancer chemoprevention: an updated review. Expert Opin Drug Metab Toxicol 2021;17:69-85. [PMID: 33074040 DOI: 10.1080/17425255.2021.1839412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
213 Onisiforou A, Spyrou GM. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Brief Bioinform 2021:bbab141. [PMID: 34237135 DOI: 10.1093/bib/bbab141] [Reference Citation Analysis]
214 Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G. Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System. Cells 2021;10:2191. [PMID: 34571840 DOI: 10.3390/cells10092191] [Reference Citation Analysis]
215 Li XC, Wu BS, Jiang Y, Li J, Wang ZF, Ma C, Li YR, Yao J, Jin XQ, Li ZQ. Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma. Drug Des Devel Ther 2021;15:1641-52. [PMID: 33907383 DOI: 10.2147/DDDT.S298261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Sun J, Ling Z, Wang F, Chen W, Li H, Jin J, Zhang H, Pang M, Yu J, Liu J. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neuroscience Letters 2016;613:30-5. [DOI: 10.1016/j.neulet.2015.12.047] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 13.2] [Reference Citation Analysis]
217 Ruffle JK, Coen SJ, Giampietro V, Williams SCR, Apkarian AV, Farmer AD, Aziz Q. Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans. Hum Brain Mapp 2018;39:381-92. [PMID: 29080228 DOI: 10.1002/hbm.23850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
218 Isaiah S, Loots DT, Solomons R, van der Kuip M, Tutu Van Furth AM, Mason S. Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis. Front Neurosci 2020;14:296. [PMID: 32372900 DOI: 10.3389/fnins.2020.00296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Kawashima Y, Watanabe E, Umeyama T, Nakajima D, Hattori M, Honda K, Ohara O. Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis. Int J Mol Sci 2019;20:E5932. [PMID: 31779068 DOI: 10.3390/ijms20235932] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
220 Mihaila D, Donegan J, Barns S, LaRocca D, Du Q, Zheng D, Vidal M, Neville C, Uhlig R, Middleton FA. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function. PLoS One 2019;14:e0218252. [PMID: 31247001 DOI: 10.1371/journal.pone.0218252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
221 da Cruz Moreira-Junior E. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease. Med Hypotheses 2019;133:109399. [PMID: 31542611 DOI: 10.1016/j.mehy.2019.109399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol 2018;78:156-66. [PMID: 29089181 DOI: 10.1016/j.jaad.2017.07.055] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
223 Tse JKY. Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders. ACS Chem Neurosci 2017;8:1438-47. [PMID: 28640632 DOI: 10.1021/acschemneuro.7b00176] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 16.3] [Reference Citation Analysis]
224 Mulak A. A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease. Mov Disord 2018;33:398-401. [PMID: 29436731 DOI: 10.1002/mds.27304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
225 Leng J, Proudman C, Darby A, Blow F, Townsend N, Miller A, Swann J. Exploration of the Fecal Microbiota and Biomarker Discovery in Equine Grass Sickness. J Proteome Res 2018;17:1120-8. [DOI: 10.1021/acs.jproteome.7b00784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
226 Sundman MH, Chen N, Subbian V, Chou Y. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain, Behavior, and Immunity 2017;66:31-44. [DOI: 10.1016/j.bbi.2017.05.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 16.8] [Reference Citation Analysis]